Guideline on Pregnancy and Diabetes by the Society of Specialists in Perinatology (PUDER), Turkey

Basit Öğe Kaydı
dc.contributor.authorBayram, Merih
dc.contributor.authorAsyalı Biri, Aydan
dc.contributor.authorBüyükbayrak, Esra Esim
dc.contributor.authorDağlar, Halil Korkut
dc.contributor.authorErcan, Fedi
dc.contributor.authorGürsoy Erzincan, Selen
dc.contributor.authorÇorbacıoğlu Esmer, Aytül
dc.contributor.authorİnan, Cihan
dc.contributor.authorKanıt, Hakan
dc.contributor.authorKara, Özgür
dc.contributor.authorKatlan, Doruk
dc.contributor.authorNas, Tuncay
dc.contributor.authorÖcal, Ece
dc.contributor.authorSağsöz, Nevin
dc.contributor.authorSanhal, Cem Yaşar
dc.contributor.authorŞahin, Güler
dc.contributor.authorTimur, Hakan
dc.contributor.authorTurhan, Uğur
dc.contributor.authorGençosmanoğlu Türkmen, Gülay
dc.contributor.authorTurkyılmaz, Gurcan
dc.contributor.authorBilgin Yanık, Filiz Fatma
dc.contributor.authorAytaç Yüksel, Mehmet
dc.date.accessioned2021-03-22T18:26:22Z
dc.date.available2021-03-22T18:26:22Z
dc.date.issued2020
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAbstract: ABS TRACT Diabetes mellitus (DM) is the most common endocrinologic problem in pregnancy. In Turkey, the reported prevalance is between 1.9-27.9%, with an average of 7.7%. While some of these cases are pregestational diabetes (PGDM), about 90% are detected during the pregnancy for the first time and diagnosed as gestational diabetes (GDM). Diabetes in pregnancy confers serious risks regarding the fetus, newborn and the mother. Therefore, we offer GDM screening for all pregnant women preferantially between 24-28 weeks of gestation. Either one-step 75-g oral glucose tolerance test (OGTT) or two-step 50-g glucose challenge test and 100-g OGTT may be used for the screening and diagnosis. In pregnancies with high-risk for DM, screening should be performed earlier, if possible, in the first antenatal visit. When GDM is diagnosed, maternal glycemic control is tried to be achieved by diet and exercise program, and if necessary, by using insulin. The use of metformin or glyburide in pregnancy is also possible. In women with the diagnosis of DM before pregnancy, preconceptional control of plasma glucose levels is of utmost importance in order to prevent adverse pregnancy outcomes. In pregnancies with GDM regulated by diet and exercise, pregnancy follow-up may be performed as in the low risk group without any pregnancy complications. If maternal or fetal distress is not observed, delivery is planned between 39+0 -40+6 weeks. Although caesarean section is recommended when estimated fetal weight is 4500 g or more, the mode of delivery may be decided more appropriately on a case-by-case basis.en_US
dc.identifier.citationBAYRAM M,BİRİ A. A,BÜYÜKBAYRAK E. E,DAĞLAR H. K,ERCAN F,ERZİNCAN S. G,ESMER A. Ç,İNAN C,KANIT H,KARA Ö,KATLAN D,NAS T,ÖCAL E,SAĞSÖZ N,SANHAL C. Y,ŞAHİN G,TİMUR H,TURHAN U,TÜRKMEN G. G,TURKYILMAZ G,YANIK F. F. B,YÜKSEL M. A (2020). Guideline on Pregnancy and Diabetes by the Society of Specialists in Perinatology (PUDER), Turkey. Journal of Clinical Obstetrics & Gynecology, 30(1), 35 - 42. Doi: 10.5336/jcog.2020-74356en_US
dc.identifier.doi10.5336/jcog.2020-74356en_US
dc.identifier.endpage42en_US
dc.identifier.issn2619-9467
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85095703736en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage35en_US
dc.identifier.trdizinid366018en_US
dc.identifier.urihttps://doi.org/10.5336/jcog.2020-74356
dc.identifier.urihttps://hdl.handle.net/11616/19674
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/366018
dc.identifier.volume30en_US
dc.identifier.wosWOS:000871239600007en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.relation.ispartofJournal of Clinical Obstetrics & Gynecologyen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleGuideline on Pregnancy and Diabetes by the Society of Specialists in Perinatology (PUDER), Turkeyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Makale Dosyası.pdf
Boyut:
221.03 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu